Tonix Pharma (TNXP) Misses Q1 EPS by 35c

Tonix Pharma (NASDAQ: TNXP) reported Q1 EPS of ($2.93), $0.35 worse than the analyst estimate of ($2.58). Revenue for the quarter came in at $6.88 million versus the consensus estimate of $9.2 million.

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

You May Also Be Interested In

• Anthropic plans IPO potentially exceeding SpaceX's $86B record - Bloomberg
• Two Binance Employees Detained In The U.A.E. Amid Police Inquiries - NYT
• Exchange Bank declares Q3 dividend, CEO to retire in 2027